NASDAQ:PCRX
Pacira Pharmaceuticals Stock News
$30.33
-0.130 (-0.427%)
At Close: May 31, 2024
Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021
08:00am, Tuesday, 09'th Mar 2021
-- EXPAREL average daily sales at 103% of the prior year for the month of February 2021 -- PARSIPPANY, N.J., March 09, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry le
Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference
07:30am, Wednesday, 03'rd Mar 2021
PARSIPPANY, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 Barclays Global Healthcare Conference at 10:55 AM ET on Tu
Pacira's (PCRX) Q4 Earnings Top Estimates, Revenues Miss
09:51am, Friday, 26'th Feb 2021
Pacira's (PCRX) earnings in the fourth quarter of 2020 beat estimates while revenues miss the same. Exparel sales rise year over year.
Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q4 2020 Results - Earnings Call Transcript
03:22pm, Thursday, 25'th Feb 2021
Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q4 2020 Results - Earnings Call Transcript
Pacira (PCRX) Q4 Earnings Beat Estimates
10:39am, Thursday, 25'th Feb 2021
Pacira (PCRX) delivered earnings and revenue surprises of 6.10% and -0.89%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Pacira to Report 2020 Financial Results on Thursday February 25, 2021
07:30am, Thursday, 18'th Feb 2021
PARSIPPANY, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its fourth quarter and year ended December 31, 2020 financial results bef
Cisco, Lyft, Uber, VMware and More Thursday Afternoon Analyst Calls
12:29pm, Thursday, 11'th Feb 2021
With the trading day more than halfway over, the broad markets were trading sideways on Thursday.
Pacira BioSciences Announces Equity Investment in GeneQuine Biotherapeutics
08:00am, Tuesday, 26'th Jan 2021
Supports Development of Promising Gene Therapy Platform for Osteoarthritis Supports Development of Promising Gene Therapy Platform for Osteoarthritis
AMRX or PCRX: Which Is the Better Value Stock Right Now?
12:47pm, Friday, 15'th Jan 2021
AMRX vs. PCRX: Which Stock Is the Better Value Option?
Pacira BioSciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
07:30am, Wednesday, 06'th Jan 2021
PARSIPPANY, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences , Inc. (NASDAQ: PCRX) today announced that it will present at the 39th Annual J.P. Morgan Healthcare Conference at 7:30 AM ET on
Pacira BioSciences Reports Preliminary Net Product Sales of $38.9 Million for November 2020
07:30am, Wednesday, 09'th Dec 2020
-- EXPAREL average daily sales at 103% of the prior year for the month of November 2020 -- PARSIPPANY, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the leading prov
--Approval based on four pivotal studies showing EXPAREL reduced pain scores and opioid use following surgery-- --EXPAREL is the first long-acting non-opioid option for field block and brachial plexus
Pacira BioSciences Reports Preliminary Net Product Sales of $41.7 Million for October 2020
08:00am, Wednesday, 11'th Nov 2020
-- EXPAREL average daily sales at 112% of the prior year for the month of October 2020 -- -- EXPAREL average daily sales at 112% of the prior year for the month of October 2020 --
Pacira BioSciences to Present at the 2020 Jefferies Virtual London Healthcare Conference
07:30am, Tuesday, 10'th Nov 2020
PARSIPPANY, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences , Inc. (NASDAQ: PCRX) today announced that it will present at the 2020 Jefferies Virtual London Healthcare Conference at 2:05 PM
Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q3 2020 Results - Earnings Call Transcript
03:46pm, Thursday, 29'th Oct 2020
Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q3 2020 Results - Earnings Call Transcript
